Many breast cancer patients take high doses of antioxidants despite possible consequences

	Tweet

A new study finds that many women with breast cancer take antioxidant supplements while undergoing cancer treatment, even though the consequences of doing so are unknown. Published in the July 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that additional research should be undertaken to determine the effects of antioxidant supplementation on the health and survival of breast cancer patients.

Antioxidant supplements include vitamin C, vitamin E, beta-carotene, and selenium. They are found in individual supplements as well as in many multivitamins. Many breast cancer patients believe that antioxidant supplements will protect them from the side effects of breast cancer treatment, help prevent breast cancer recurrence, and improve their overall health. However, the actual effects of taking antioxidants during cancer treatment are poorly understood and the findings to date are mixed. Some physicians believe antioxidants may in fact interfere with radiation and some types of chemotherapy, which often attacks tumor cells by generating reactive oxygen species (ROS), very small molecules that play a role in cell development.

Researchers led by Heather Greenlee, ND, PhD, Assistant Professor of Epidemiology and Medical Oncology (in Medicine) at Columbia University Mailman School of Public Health in New York, investigated the prevalence of antioxidant use in women with breast cancer who participated in the population-based Long Island Breast Cancer Study Project (LIBCSP).

LIBCSP, which included more than 1,500 breast cancer patients, began as a federally mandated study that investigated whether breast cancer risk was associated with environmental exposures among women in Nassau and Suffolk counties in New York State. Dr. Greenlee’s study is based on the 764 patients who completed a follow-up interview and provided information on antioxidant supplement use.

Among the 764 patients studied, 663 women (86.8 percent) reported receiving chemotherapy, radiation, or hormone therapy for breast cancer. Of these 663 women, six in ten (60.5 percent) reported using antioxidants during breast cancer treatment, which included chemotherapy, radiation, and tamoxifen (anti-estrogen) therapy.

About seven in ten antioxidant users (69.3 percent) used high doses, defined as higher than the dose contained in a Centrum multivitamin. Women who took high doses of antioxidants during treatment were more likely to be using tamoxifen and to have a history of eating more fruits and vegetables, using herbal products, and engaging in mind-body practices.

“Given the common use of antioxidant supplements during breast cancer treatment, often at high doses and in conjunction with other complementary therapies, future research should address the effects of antioxidant supplementation on breast cancer outcomes,” including whether antioxidants affect treatment toxicities, treatment efficacy, cancer recurrence, and survival, say the authors.

###

Article: “Prevalence and predictors of antioxidant supplement use during breast cancer treatment: The Long Island Breast Cancer Study Project.” Heather Greenlee, Marilie D. Gammon, Page E. Abrahamson, Mia M. Gaudet, Mary Beth Terry, Dawn L. Hershman, Manisha Desai, Susan L. Teitelbaum Alfred I. Neugut, and Judith S. Jacobson. CANCER; Published Online: June 08, 2009 (DOI: 10.1002/cncr.24378); Print Issue Date: July 15, 2009.

Contact: David Sampson

American Cancer Society

RELATED STORIES:
New MRI Technique Could Mean Fewer Breast Biopsies in High-Risk Women   Breast cancer tumor growth estimated through mammography screening data   Cell of Origin Identified for Common Type of Breast Cancer   Annual screening with breast ultrasound or MRI could benefit some women   Racial differences in severity of breast cancer presentation confirmed   Virus kills breast cancer cells in laboratory   Understanding And Treating Triple-Negative Breast Cancer   Common Genetic Variation Impacts Breast Cancer Diagnosis in Older Women   Breast Cancer Radiation Does Not Affect Women’s Immune System   Linchpin Gene May Be Useful Target For Breast Cancer Therapies   Partial Breast Radiation Focus of New Cancer Study   The ‘2-week wait rule’ is failing breast cancer patients   Scientists pinpoint new breast cancer genes   DACH1 a key protein for tumor suppression in ER+ breast cancer   African-American women with advanced breast cancer often forego vital treatment   Size of Family Could Affect Predicting Breast Cancer Risk   Wet ear wax and unpleasant body odors signal breast cancer risk   Implications for Fine-Tuned Breast Cancer Prognosis Unveiled   Breast Cancer Brachytherapy May Be Overused   In Flurry of Studies, Researcher Details Role of Apples in Inhibiting Breast Cancer   Women Take Charge of Breast Cancer in Different Ways: Sociologist Studies Responder Types and Effica   Acupuncture May Relieve Joint Pain Caused by Some Breast Cancer Treatments

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]